EMA accelerates enforcement of clinical trial transparency mandates

The European Medicines Agency is expediting the enforcement of existing legal requirements for public disclosure of clinical trial results. While the specific mechanisms of this acceleration remain opaque, the move marks a shift toward stricter regulatory oversight of pharmaceutical data transparency.